Sign In
Buy CRL
$179.87
+5.08 (+2.91%)
At Close: Jun 03, 2026
Charles River (CRL) Announces Partnership With Related Sciences
09:46am, Friday, 15'th Sep 2023
Charles River's (CRL) new collaboration is likely to leverage the AI-powered drug discovery and development platform, Logica.
Here's Why You Should Retain Charles River (CRL) Stock Now
12:01pm, Wednesday, 06'th Sep 2023
Investors are optimistic about Charles River (CRL) on the RMS segment's continued growth and upbeat guidance.
Charles River (CRL) Collaborates With Fondazione Telethon
12:02pm, Friday, 25'th Aug 2023
Charles River (CRL) is excited about Fondazione Telethon's collaboration to produce HQ plasmid DNA for the lentivirus used in ex vivo gene therapy developed by Fondazione Telethon.
Charles River Lab signs joint agreement for protection of crabs used in medical tests
06:32pm, Thursday, 24'th Aug 2023
Charles River Laboratories has signed a joint agreement with four entities to enhance protections in South Carolina for horseshoe crabs and a bird that feeds on their eggs, they said on Thursday.
Charles River (CRL) Q2 Earnings Top, 2023 View Narrowed
12:57pm, Wednesday, 09'th Aug 2023
Charles River (CRL) registers robust growth in small research models, research model services and the Safety Assessment business.
Charles River Laboratories (CRL) Beats Q2 Earnings and Revenue Estimates
09:58am, Wednesday, 09'th Aug 2023
Charles River Laboratories (CRL) came out with quarterly earnings of $2.69 per share, beating the Zacks Consensus Estimate of $2.63 per share. This compares to earnings of $2.77 per share a year ago.
Is Charles River Laboratories International (CRL) Significantly Undervalued?
06:37pm, Saturday, 05'th Aug 2023
On August 5, 2023, Charles River Laboratories International Inc ( CRL , Financial) experienced a daily gain of 2.66%, with an Earnings Per Share (EPS) of 9.67. This has led to speculation about whethe
Charles River Laboratories International (CRL): A Significantly Undervalued Gem?
02:33pm, Friday, 04'th Aug 2023
With a daily gain of 3.46% and an Earnings Per Share (EPS) of 9.67, Charles River Laboratories International Inc ( CRL , Financial) has presented an intriguing question to value investors: Is the stoc
Buy Alert: 3 Healthcare Stocks Nearing Super Attractive Entry Points
11:31am, Wednesday, 02'nd Aug 2023
As a prolific cog in the economic machine, the healthcare industry has been a roller coaster ride over the past few years. With the global pandemic, economic slowdown and industry-wide disruptions in
Charles River (CRL) to Report Q2 Earnings: What's in Store?
12:38pm, Monday, 31'st Jul 2023
Continued global demand for research models and associated services' strong DSA segment performance is likely to have driven Charles River's (CRL) Q2 revenues.
Charles River Laboratories: Very Attractive After The Pullback
02:05am, Wednesday, 26'th Jul 2023
Charles River Laboratories' share price has declined over 50% from its 2021 peak, presenting a potential buying opportunity for investors. The CRO company is facing headwinds from COVID's overhang and
Here's Why You Should Retain Charles River (CRL) Stock Now
12:02pm, Monday, 17'th Jul 2023
Investors are optimistic about Charles River (CRL) on strategic acquisitions and robust performance of the DSA and RMS arms.
3 Cheap Stocks to Buy Before They Bounce Back
07:32am, Tuesday, 04'th Jul 2023
The stock market has indeed had an impressive run in the first half of the year, with the Nasdaq leading the charge and posting record gains. This bullish trend might have left some investors feeling
Charles River's (CRL) Improved Volume Aids Amid Margin Woe
11:42am, Wednesday, 14'th Jun 2023
Charles River (CRL) registers growth in small research models, research model services and the Cell Solutions business.
3 Long-term Healthcare Stocks to Add to Your Portfolio
11:21am, Wednesday, 14'th Jun 2023
One of the greatest changes in the American landscape going forward will be demographics. The Baby Boomers make up the largest generation in the country's history.
